Tanshinone IIA and astragaloside IV attenuate diabetic nephropathy by regulating the SOX6-mediated MAPK/NF-κB pathway to suppress inflammation and oxidative stress
Tanshinone IIA and astragaloside IV attenuate diabetic nephropathy by regulating the SOX6-mediated MAPK/NF-κB pathway to suppress inflammation and oxidative stress. // Tissue and Cell. – URL: https://www.sciencedirect.com/science/article/pii/S0040816626008633?dgcid=rss_sd_all
Tanshinone IIA and astragaloside IV attenuate diabetic nephropathy by regulating the SOX6-mediated MAPK/NF-κB pathway to suppress inflammation and oxidative stress. Tissue and Cell. https://www.sciencedirect.com/science/article/pii/S0040816626008633?dgcid=rss_sd_all
“Tanshinone IIA and astragaloside IV attenuate diabetic nephropathy by regulating the SOX6-mediated MAPK/NF-κB pathway to suppress inflammation and oxidative stress.” Tissue and Cell.
@article{article108875,
title = {Tanshinone IIA and astragaloside IV attenuate diabetic nephropathy by regulating the SOX6-mediated MAPK/NF-κB pathway to suppress inflammation and oxidative stress},
journal = {Tissue and Cell},
url = {https://www.sciencedirect.com/science/article/pii/S0040816626008633?dgcid=rss_sd_all}
}